RadNet, Inc. RDNT

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $76.25
Market Cap $6.08B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑11.5% YoY
$2.04B
3-Yr CAGR: 12.6%
Net Income ↓-767.8% YoY
-$18.65M
Net Margin: -0.9%
Free Cash Flow ↑90.4% YoY
$85.57M
FCF Yield: 1.41%
EPS (Diluted) ↓-725.0% YoY
$-0.25
Basic: $-0.25
Return on Equity Efficiency
-1.7%
ROA: -35.9%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (RDNT)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $884.5M $841.1M $13.5M $0.15 $91.6M $88.2M
FY 2017 $922.2M +4.3% $119.8M $0.1M -99.6% -100.0% $142.2M $80.9M -8.3%
FY 2018 $975.1M +5.7% $107.6M $32.2M +60,735.8% $0.66 $116.8M $44.6M -44.9%
FY 2019 $1,028.2M +5.4% $28.5M $14.8M -54.2% $0.29 -56.1% $104.3M $30.2M -32.3%
FY 2020 $1,098.1M +6.8% $131.9M $-14.8M -200.6% $-0.29 -200.0% $233.8M $181.8M +502.5%
FY 2021 $1,324.2M +20.6% $82.6M $24.7M +266.6% $0.46 +258.6% $149.5M $11.6M -93.6%
FY 2022 $1,430.1M +8.0% $171.8M $10.7M -56.9% $0.17 -63.0% $146.4M $27.0M +132.1%
FY 2023 $1,616.6M +13.0% $98.7M $3.0M -71.4% $0.05 -70.6% $220.9M $44.3M +64.1%
FY 2024 $1,829.7M +13.2% $104.6M $2.8M -8.2% $0.04 -20.0% $233.0M $45.0M +1.6%
FY 2025 $2,040.2M +11.5% $245.1M $-18.7M -767.8% $-0.25 -725.0% $298.8M $85.6M +90.4%
$

Valuation

Market Price $76.25
Market Cap $6.08B
Enterprise Value $6.40B
P/E Ratio N/A
P/B Ratio 5.50
FCF Yield 1.41%
Dividend Yield N/A
Shares Outstanding 78,634,200
%

Profitability & Margins

Gross Margin 12.01%
Operating Margin 3.04%
Net Margin -0.91%
Return on Equity (ROE) -1.71%
Return on Assets (ROA) -35.87%
Asset Turnover 39.23x
Revenue 3-Yr CAGR 12.57%
🛡️

Financial Health & Liquidity

Current Ratio 0.34
Cash Ratio 4.95
Debt / Equity 1.000
Debt / Assets 20.959
Cash & Equivalents $767.22M
Total Debt $1.09B
Book Value / Share $13.86
💧

Cash Flow Efficiency

Operating Cash Flow $298.82M
Capital Expenditures (CapEx) $213.25M
Free Cash Flow $85.57M
OCF / Revenue 14.65%
FCF / Revenue 4.19%
FCF 3-Yr CAGR 46.95%
🏷️

Per Share Metrics

EPS (Diluted) $-0.25
EPS (Basic) $-0.25
Dividends / Share N/A
Book Value / Share $13.86
EPS YoY Growth -725.00%
🏛️

Balance Sheet (FY 2025)

Total Assets $52.00M
Total Liabilities $154.99M
Stockholders' Equity $1.09B
Current Assets $52.00M
Current Liabilities $154.99M